...
【24h】

Day-case percutaneous left atrial appendage occlusion-Safety and efficacy

机译:Day-case经皮左心房附件occlusion-Safety和有效性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives We evaluated the safety and efficacy of percutaneous left atrial appendage (LAA) occlusion performed as a day case procedure. Background LAA occlusion has been shown to be safe and effective for stroke prevention in patients with atrial fibrillation. It has not been shown if the procedure can safely be performed on a day-case basis. Methods Retrospective analysis was made of 117 LAA occlusion procedures in a single large teaching hospital in the UK. Procedural success, procedural complications, length of stay, and readmission data were examined. Results Successful deployment of a device was possible in all but one patient (whose appendage was too large). Major in-hospital complications occurred in 1.7% of patients (both femoral vascular). Same-day discharge was made in 66% of patients overall. Since January 2016, only 3 of 59 patients (5%) have remained in hospital overnight following LAAO. Echocardiography 2-4 hr postprocedure was undertaken prior to discharge. One patient was readmitted within 7 days but this readmission would not have been prevented by overnight stay. Conclusions LAA occlusion can be safely performed as a day case procedure with acceptable complication rates and no increment of complications related to the lack of routine overnight stay.
机译:目标我们评估的安全性和有效性经皮左心耳(LAA)一天闭塞表现过程。背景LAA闭塞已被证明安全有效的预防中风心房纤颤患者。如果过程可以安全地day-case基础上执行。回顾性分析117 LAA在一个大型教学阻塞过程在英国医院。程序性的并发症,住院时间,重新接纳数据检查。成功部署的设备是可能的一个病人(其附件太大)。1.7%的患者(包括股血管)。当天放电是在66%的病人整体。例(5%)仍在医院过夜LAAO。postprocedure排放之前进行。但这一个病人重新在7天重新接纳就不会被阻止住宿。每天安全地执行程序可以接受的并发症发生率并没有增加缺乏常规的并发症相关住宿。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号